ArQule Derivative Compound definition

ArQule Derivative Compound means a Derivative Compound synthesized by ArQule from an ArQule Compound under the Directed Array(TM) Program described in Section 3.3.
Sample 1Sample 2
ArQule Derivative Compound means a chemical compound generated by ArQule for Abbott or by Abbott, its Affiliates or contractors by use of chemical modification methods from an ArQule Core Compound.
Sample 1Sample 2Sample 3
ArQule Derivative Compound means a Derivative Compound synthesized by ArQule from an ArQule Compound under the Directed Array (tm) Program described in Section 4.
Sample 1

Examples of ArQule Derivative Compound in a sentence

  • ArQule and Monsanto will jointly own any Patent Rights applied for or obtained by either Party covering any method of making or using any ArQule Compound, ArQule Derivative Compound, Monsanto Compound or Monsanto Derivative Compound where such method is invented jointly by Monsanto and ArQule.

  • ArQule will solely own any Patent Rights applied for or obtained by either Party covering (i) ArQule Compounds or ArQule Derivative Compounds not owned by Monsanto pursuant to 5.1(a), or (ii) any method of making or using any ArQule Compound, ArQule Derivative Compound, Monsanto Compound or Monsanto Derivative Compound where such method is invented solely by ArQule.

  • With respect to infringement of any Solvay Patent Right or any ArQule Patent Right or Joint Patent Right exclusively licensed to Solvay claiming the composition or use of a Licensed Compound, ArQule Derivative Compound, or Royalty-Bearing Product, Solvay shall have the primary right, but not the obligation, to enforce such Patent Right under its sole control and at its sole expense.

  • The Parties intend that ArQule will produce approximately [ ]* of each ArQule Derivative Compound in the Directed Arrays, subject to the availability of the original Monsanto Compounds and/or the ArQule Compounds; PROVIDED, HOWEVER that the amount of each ArQule Derivative Compound that ArQule actually produces will ultimately be determined by the Research Committee.

  • With respect to infringement of any Sankyo Patent Right claiming the composition or use of a Licensed Compound, ArQule Derivative Compound, or Royalty-Bearing Product, Sankyo shall have the primary right, but not the obligation, to enforce such Patent Right under its sole control and at its sole expense.

  • Monsanto will solely own any Patent Rights filed by either Party covering any method of making or using any ArQule Compound, ArQule Derivative Compound, Monsanto Compound or Monsanto Derivative Compound where such method is invented solely by Monsanto.

  • During the term of the Directed Array™ Program, any ArQule Derivative Compound and any Wyeth-Ayerst Derivative Compound selected for resynthesis pursuant to this Agreement shall be reproducible by ArQule in quantities of at least * or such other reasonable quantity as determined by the Research Committee.

  • The Parties also intend that ArQule will produce approximately twenty (20) milligrams of each ArQule Derivative Compound and/or Sankyo Derivative Compound in the Directed Arrays (tm), subject to the availability of the original Sankyo Compounds and/or the ArQule Compounds; provided, however, that the amount of each ArQule Derivative Compound and/or Sankyo Derivative Compound that ArQule actually produces will ultimately be determined by the Steering Committee.

  • The Parties intend that ArQule will produce approximately twenty (20) milligrams of each ArQule Derivative Compound in the Directed Arrays, subject to the availability of the original Monsanto Compounds and/or the ArQule Compounds; provided, however that the amount of each ArQule Derivative Compound that ArQule actually produces will ultimately be determined by the Research Committee.

  • During the term of the Directed Array(TM) Program, any ArQule Derivative Compound and any Wyeth-Ayerst Derivative Compound selected for resynthesis pursuant to this Agreement shall be reproducible by ArQule in quantities of at least ***** or such other reasonable quantity as determined by the Research Committee.


More Definitions of ArQule Derivative Compound

ArQule Derivative Compound means a Derivative Compound developed from a Licensed Compound [*****].
Sample 1Sample 2
ArQule Derivative Compound means a Derivative Compound that is derived from an ArQule Compound in the course of a development program for the molecular target or other target (e.g., whole cell screen) against which the ArQule Compound was initially discovered to have biological activity, i.e., a compound is not an ArQule Derivative Compound if that compound is independently developed by Monsanto for a different target.
Sample 1
ArQule Derivative Compound means a Derivative Compound developed from a Licensed Compound in the course of an optimization program for the molecular Target or other Target (e.g., whole cell screen) against which such Licensed Compound was initially discovered to have biological activity, i.e., a compound is not an ArQule Derivative Compound if that compound is independently developed by Sankyo.
Sample 1
ArQule Derivative Compound. 1.9. "ArQule Patent Rights" 1,10. "ArQule Technology" 1.11. "Array" 1.12. "Base Rate of Interest" 1.13. "Chemical Theme" 1.14. "Confidential Information" 1.15. "Contract Year" 1.16. "Derivative Compound" 1.17. "Directed Array (tm)" 1.18. "Directed Array (tm) Program" 1.19. "Disclosing Party" 1.20. "Effective Date" 1.21. "Extraordinary Expenses" 1.22. "FDA" 1.23. "Joint Patent Rights" 1.24. "Licensed Compound" 1.25. "Licensed Compound Set" 1.26. "Mapping Array (tm)" 1.27. "Mapping Array (tm) Program" 1.28. "Net Sales" 1.29. "Net Sales Price" 1.30. "Party" 1.31. "Patent Rights" 1.32. "Phase I Clinical Trials" 1.33. "Phase II Clinical Trials" 1.34. "Phase III Clinical Trials" 1.35. "Preclinical Compound" 1.36. "Preclinical Development" 1.37. "Receiving Party" 1.38. "Research Period" 1.39. "Research Program" 1.40. "Research Plan" 1.41. "Royalty-Bearing Product" 1.42. "Royalty Period" EXHIBIT 10.16
Sample 1

Related to ArQule Derivative Compound

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Licensed Compound means [***].

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Compounds means a small molecule HMT inhibitor.

  • Derivative Product means a written contract or agreement between the Authority and a Reciprocal Payor, which provides that the Authority’s obligations thereunder will be conditioned on the absence of (a) a failure by the Reciprocal Payor to make any payment required thereunder when due and payable, or (b) a default thereunder with respect to the financial status of the Reciprocal Payor; and:

  • Product Technology means the Product Know-How and Product Patents.

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Program Patent Rights means any Patent Rights that are Controlled by one or both parties and that Cover any Program Technology or Program Materials. For clarification, such Program Patent Rights include the entire scope of all of the claims contained in such Patent Rights.

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Program Technology means Program Know-How and Program Patents.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Product Patents means any Patent Controlled or owned by Quoin in the Territory that, absent the license in Section 2.1, would be infringed by the importation, sale, or use of the Product in the Territory by a third party.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Collaboration Patents means any and all Patents that claim or cover any of the Collaboration Know-How.

  • Licensed Product means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Commercialized shall have corresponding meanings.